High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia. [electronic resource]
Producer: 20201111Description: 3123 p. digitalISSN:- 1664-3224
- Alpharetrovirus -- genetics
- Antigens, CD19 -- immunology
- Cell Line, Tumor
- Cytotoxicity, Immunologic
- Genetic Engineering
- Genetic Vectors
- Humans
- Immunotherapy, Adoptive -- methods
- Killer Cells, Natural -- physiology
- Lentivirus -- genetics
- Peptides -- metabolism
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- immunology
- Receptors, Antigen, T-Cell -- genetics
- Transduction, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.